Literature DB >> 17932716

Pleural mesothelial cells mediate inflammatory and profibrotic responses in talc-induced pleurodesis.

Milena Marques P Acencio1, Francisco S Vargas, Evaldo Marchi, Gabriela G Carnevale, Lisete R Teixeira, Leila Antonangelo, V Courtney Broaddus.   

Abstract

Intrapleural talc is used to produce pleurodesis in malignant pleural effusions. Prior in vivo studies have documented an acute inflammatory response to talc in the pleural space but the cellular source of cytokines has not been identified. The aim of this study was to investigate the acute response of rabbit pleural mesothelial cells challenged with talc used for pleurodesis and compare it to prior studies of the response to talc in the rabbit pleural space. Cultured rabbit pleural mesothelial cells (PMC) were exposed to talc (25 mug/cm(2)) for 6, 24, or 48 h and assessed for viability, necrosis, and apoptosis by flow cytometry, Trypan Blue exclusion, and immunocytochemistry, and for the production of interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), and transforming growth factor-beta(1) (TGF-beta(1)) by ELISA. More than 50% of the PMC remained viable 48 h after talc stimulation. The PMC that were nonviable were identified as either apoptotic or necrotic, with roughly 20% in each category over the 48 h. At 6 h, the IL-8, VEGF, and TGF-beta(1) levels produced by talc-exposed PMC increased significantly and remained elevated for up to 48 h. These cytokine levels rose at similar times and at the same or higher levels than have been measured in the rabbit pleural space in prior studies. We report that viable, talc-exposed, pleural mesothelial cells may actively mediate the primary inflammatory pleural response in talc-induced pleurodesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932716     DOI: 10.1007/s00408-007-9041-y

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  18 in total

1.  Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis.

Authors:  E Marchi; F S Vargas; M M Acencio; L Antonangelo; E H Genofre; L R Teixeira
Journal:  Eur Respir J       Date:  2006-07-26       Impact factor: 16.671

2.  Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.

Authors:  D L Hartman; J M Gaither; K A Kesler; D M Mylet; J W Brown; P N Mathur
Journal:  J Thorac Cardiovasc Surg       Date:  1993-04       Impact factor: 5.209

3.  A single intrapleural injection of transforming growth factor-beta(2) produces an excellent pleurodesis in rabbits.

Authors:  R W Light; D S Cheng; Y C Lee; J Rogers; J Davidson; K B Lane
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

4.  Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits.

Authors:  A M Boylan; C Rüegg; K J Kim; C A Hébert; J M Hoeffel; R Pytela; D Sheppard; I M Goldstein; V C Broaddus
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

5.  Mesothelial cell apoptosis is confirmed in vivo by morphological change in cytokeratin distribution.

Authors:  E Marchi; W Liu; V C Broaddus
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-03       Impact factor: 5.464

6.  Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis.

Authors:  Veena B Antony; Najmunnisa Nasreen; Kamal A Mohammed; Peruvenba S Sriram; Wolfgang Frank; Nicolas Schoenfeld; Robert Loddenkemper
Journal:  Chest       Date:  2004-11       Impact factor: 9.410

7.  Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro.

Authors:  Y C Gary Lee; Dee Melkerneker; Philip J Thompson; Richard W Light; Kirk B Lane
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

8.  The effect of common sclerosing agents on the rabbit pleural space.

Authors:  S A Sahn; J T Good
Journal:  Am Rev Respir Dis       Date:  1981-07

Review 9.  Structure and function of mesothelial cells.

Authors:  S E Mutsaers; S Wilkosz
Journal:  Cancer Treat Res       Date:  2007

Review 10.  Pathogenesis of pleural infection.

Authors:  Chadi A Hage; Kamal abdul-Mohammed; Veena B Antony
Journal:  Respirology       Date:  2004-03       Impact factor: 6.424

View more
  11 in total

1.  Identification of a novel developmental mechanism in the generation of mesothelia.

Authors:  Nichelle I Winters; Rebecca T Thomason; David M Bader
Journal:  Development       Date:  2012-07-04       Impact factor: 6.868

2.  Impact of Factors Secreted by Tumor Cells on Response of Pleural Mesothelial Cells to Different Sclerosing Agents in an In Vitro Model.

Authors:  Michał Mierzejewski; Magdalena Paplińska-Goryca; Rafał Krenke
Journal:  Med Sci Monit       Date:  2022-05-10

3.  Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.

Authors:  Sophia Karandashova; Galina Florova; Ali O Azghani; Andrey A Komissarov; Kathy Koenig; Torry A Tucker; Timothy C Allen; Kris Stewart; Amy Tvinnereim; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2012-09-20       Impact factor: 6.914

4.  Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats.

Authors:  Igor Bastos Polonio; Milena Marques Pagliareli Acencio; Rogério Pazetti; Francine Maria de Almeida; Bárbara Soares da Silva; Karina Aparecida Bonifácio Pereira; Rogério Souza
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

5.  Role of talc modulation on cytokine activation in cancer patients undergoing pleurodesis.

Authors:  Yehuda Schwarz; Alex Star
Journal:  Pulm Med       Date:  2012-03-07

6.  Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin.

Authors:  Olivier Burgy; Pierre-Simon Bellaye; Sebastien Causse; Guillaume Beltramo; Guillaume Wettstein; Pierre-Marie Boutanquoi; Françoise Goirand; Carmen Garrido; Philippe Bonniaud
Journal:  Respir Res       Date:  2016-11-29

7.  Novel approach to pleurodesis with 50 % glucose for air leakage after lung resection or pneumothorax.

Authors:  Kosuke Fujino; Yamato Motooka; Takamasa Koga; Hironobu Osumi; Eri Matsubara; Hidekatsu Shibata; Koei Ikeda; Kenji Shiraishi; Takeshi Mori; Koji Hayashi; Kentaro Yoshimoto; Jyoeji Wakimoto; Ichiro Kubota; Makoto Suzuki
Journal:  Surg Today       Date:  2015-07-24       Impact factor: 2.549

8.  Impact of systemic steroid treatment on talc pleurodesis: a report of six cases.

Authors:  Soichiro Ishii; Hiroshi Sakurashita; Emiko Mashida; Yasuyuki Saeki; Hiroaki Matsuo
Journal:  J Pharm Health Care Sci       Date:  2020-07-03

9.  TLR2 in pleural fluid is modulated by talc particles during pleurodesis.

Authors:  Karolina Jankovicova; Katerina Kondelkova; Petr Habal; Ctirad Andrys; Jan Krejsek; Jiri Mandak
Journal:  Clin Dev Immunol       Date:  2012-12-10

10.  Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory Study.

Authors:  Horiana B Grosu; Wei Lu; David E Ost; Macarena R Vial; Mike Hernandez; Natasha Ghosh; Laila Noor; Arain M Hasan; Lara Bashoura; Saadia Faiz; Dave Balachandran; Roberto Casal; George Eapen; Vickie Shannon; Ajay Sheshadri; Ximing Tang; Najib Rahman; Ignacio I Wistuba
Journal:  J Bronchology Interv Pulmonol       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.